Revenue decreased 10.8%
Revenue changed -10.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$188.4M→$168.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MPAA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -234.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$9.2M→-$12.4M2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -212.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$10.0M→-$11.3M2 prior comparisons
Stock-based compensation increased 126.0%
Stock-based compensation changed +126.0% from the comparable as-filed period.
$946,000→$2.1M2 prior comparisons
Free-cash-flow margin moved 1228 bp lower
Free-cash-flow margin changed -1228 basis points from the comparable as-filed period.
4.90%→-7.39%2 prior comparisons
Operating cash-flow margin moved 1205 bp lower
Operating cash-flow margin changed -1205 basis points from the comparable as-filed period.
5.32%→-6.73%2 prior comparisons
Gross profit decreased 19.9%
Gross profit changed -19.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$33.9M→$27.2M2 prior comparisons
Capital expenditure increased 37.3%
Capital expenditure changed +37.3% from the comparable as-filed period.
$807,000→$1.1M2 prior comparisons
Receivables / revenue moved 294 bp lower
Receivables / revenue changed -294 basis points from the comparable as-filed period.
45.41%→42.47%2 prior comparisons
Inventory increased 12.7%
Inventory changed +12.7% from the comparable as-filed period.
$366.8M→$413.3M3 prior comparisons
Trade receivables decreased 16.6%
Trade receivables changed -16.6% from the comparable as-filed period.
$85.5M→$71.4M3 prior comparisons
Working capital increased 9.0%
Working capital changed +9.0% from the comparable as-filed period.
$158.8M→$173.0M3 prior comparisons
Current assets increased 8.6%
Current assets changed +8.6% from the comparable as-filed period.
$519.4M→$564.2M3 prior comparisons
Current liabilities increased 8.5%
Current liabilities changed +8.5% from the comparable as-filed period.
$360.6M→$391.2M3 prior comparisons
SBC / revenue moved 77 bp higher
SBC / revenue changed +77 basis points from the comparable as-filed period.
0.50%→1.27%2 prior comparisons
Research & development decreased 3.9%
Research & development changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$3.3M→$3.2M2 prior comparisons
Total assets increased 3.8%
Total assets changed +3.8% from the comparable as-filed period.
$973.4M→$1.0B3 prior comparisons
Capex / revenue moved 23 bp higher
Capex / revenue changed +23 basis points from the comparable as-filed period.
0.43%→0.66%2 prior comparisons
Working capital / assets moved 82 bp higher
Working capital / assets changed +82 basis points from the comparable as-filed period.
16.31%→17.13%3 prior comparisons
R&D / revenue moved 14 bp higher
R&D / revenue changed +14 basis points from the comparable as-filed period.
1.76%→1.89%2 prior comparisons
Current ratio increased 0.1%
Current ratio changed +0.1% from the comparable as-filed period.
1.44→1.443 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.